Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 26:2018:7656752.
doi: 10.1155/2018/7656752. eCollection 2018.

Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance

Dong Sup Lee  1 , Seung-Ju Lee  1 , Hyun-Sop Choe  1
Affiliations
Review

Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance

Dong Sup Lee et al. Biomed Res Int. .

Abstract

Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) are the most common types of infections in women. The antibiotic resistance of E. coli is increasing rapidly, causing physicians to hesitate when selecting oral antibiotics. In this review, our objective is to ensure that clinicians understand the current seriousness of antibiotic-resistant E. coli, the mechanisms by which resistance is selected for, and methods that can be used to prevent antibiotic resistance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Worldwide susceptibilities of E. coli to oral antibiotics in community-acquired urinary tract infections in the last decade.
See this image and copyright information in PMC

References

    1. Gupta K., Hooton T. M., Stamm W. E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Annals of Internal Medicine. 2001;135(1):41–50. doi: 10.7326/0003-4819-135-1-200107030-00012. - DOI - PubMed
    1. Kang C., Kim J., Park D. W., et al. Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections. Infection & Chemotherapy. 2018;50(1):67–100. doi: 10.3947/ic.2018.50.1.67. - DOI - PMC - PubMed
    1. Gupta K., Hooton T. M., Naber K. G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases. 2011;52(5):e103–e120. doi: 10.1093/cid/ciq257. - DOI - PubMed
    1. Harrison J. W., Svec T. A. The beginning of the end of the antibiotic era? Part I. The problem: Abuse of the “miracle drugs”. Quintessence International. 1998;29(3):151–162. - PubMed
    1. Baquero F. Low-level antibacterial resistance: A gateway to clinical resistance. Drug Resistance Updates. 2001;4(2):93–105. doi: 10.1054/drup.2001.0196. - DOI - PubMed

MeSH terms

Substances